US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 2.0200
  • +0.0100+0.50%
Close Oct 1 16:00 ET
413.99MMarket Cap-4122P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
37.70%-17.95M
43.73%-18.77M
50.69%-20.19M
24.48%-88.39M
136.54%14.71M
9.78%-28.81M
Net income from continuing operations
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
-341.39%-117.09M
27.85%-24.6M
64.98%-17.62M
4.88%-166.01M
-9.31%-55.08M
48.18%-26.53M
Operating gains losses
---195K
--337K
--36.95M
---63.51M
----
----
----
----
----
----
Depreciation and amortization
-6.12%322K
-1.81%325K
16.98%1.37M
1.10%366K
19.49%331K
25.64%343K
27.31%331K
138.21%1.17M
73.21%362K
66.87%277K
Other non cash items
-93.92%247K
-75.47%105K
167.01%9.27M
198.26%1.71M
399.35%3.07M
666.42%4.06M
-75.58%428K
-65.76%3.47M
-80.46%574K
-59.23%614K
Change In working capital
-437.94%-4.28M
105.96%298K
-197.27%-18.01M
-117.11%-4.85M
3.57%-7.37M
81.07%-796K
-345.43%-5M
-35.40%18.52M
1,298.37%28.33M
-161.17%-7.64M
-Change in prepaid assets
-9.57%822K
-73.25%-693K
187.88%6.01M
1,754.63%2M
84.16%3.5M
575.92%909K
-247.60%-400K
162.12%2.09M
105.90%108K
8.45%1.9M
-Change in payables and accrued expense
-678.55%-3.99M
3,938.53%4.4M
49.95%-8.57M
39.13%-3.25M
35.83%-6.12M
117.19%690K
-93.82%109K
-153.48%-17.13M
-238.29%-5.33M
-188.83%-9.54M
-Change in other working capital
53.57%-1.11M
27.52%-3.41M
-146.04%-15.45M
---3.6M
---4.75M
---2.4M
---4.71M
--33.56M
----
----
Cash from discontinued investing activities
Operating cash flow
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
37.70%-17.95M
43.73%-18.77M
50.69%-20.19M
24.48%-88.39M
136.54%14.71M
9.78%-28.81M
Investing cash flow
Cash flow from continuing investing activities
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
-15.56%-3.49M
100.59%48K
65.87%-3.9M
-15.66%-24.93M
72.18%-2.37M
24.54%-3.02M
Net PPE purchase and sale
-518.75%-201K
96.41%-140K
81.24%-3.87M
99.26%-17K
--0
100.61%48K
53.72%-3.9M
-34.73%-20.62M
72.08%-2.31M
42.32%-2.02M
Net intangibles purchase and sale
----
----
17.65%-3.5M
--0
----
----
----
32.00%-4.25M
--0
-100.00%-1M
Net other investing changes
----
----
127.87%17K
--7K
----
----
----
---61K
----
----
Cash from discontinued investing activities
Investing cash flow
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
-15.56%-3.49M
100.59%48K
65.87%-3.9M
-15.66%-24.93M
72.18%-2.37M
24.54%-3.02M
Financing cash flow
Cash flow from continuing financing activities
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
136,637.86%140.63M
-96.60%377K
-245.79%-370K
33.30%52.1M
352.85%41.23M
-100.34%-103K
Net issuance payments of debt
----
----
---3.45M
----
----
----
----
--0
----
----
Net common stock issuance
----
----
164.42%140.79M
-101.02%-423K
--140.71M
----
----
--53.24M
--41.6M
--0
Proceeds from stock option exercised by employees
--0
-48.00%26K
-73.12%68K
--0
126.47%18K
--0
-81.95%50K
--253K
--0
---68K
Net other financing activities
89.43%-13K
88.57%-48K
27.50%-1.02M
-0.81%-375K
-177.14%-97K
79.80%-123K
-9.38%-420K
-60.18%-1.4M
---372K
---35K
Cash from discontinued financing activities
Financing cash flow
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
136,637.86%140.63M
-96.60%377K
-245.79%-370K
33.30%52.1M
352.85%41.23M
-100.34%-103K
Net cash flow
Beginning cash position
91.61%126.58M
61.89%146.54M
-40.35%90.52M
351.82%166.92M
-30.72%47.72M
-33.45%66.06M
-40.35%90.52M
-39.61%151.74M
-80.70%36.94M
-65.10%68.88M
Current changes in cash
365.85%48.76M
18.38%-19.96M
191.51%56.02M
-138.03%-20.38M
473.27%119.2M
39.65%-18.34M
53.40%-24.46M
38.48%-61.22M
235.04%53.57M
-436.06%-31.93M
End cash Position
267.44%175.34M
91.61%126.58M
61.89%146.54M
61.89%146.54M
351.82%166.92M
-30.72%47.72M
-33.45%66.06M
-40.35%90.52M
-40.35%90.52M
-80.70%36.94M
Free cash flow
-15.95%-21.71M
17.22%-19.94M
29.02%-80.39M
-230.08%-16.13M
32.61%-21.45M
54.86%-18.72M
54.01%-24.09M
18.28%-113.26M
125.43%12.4M
11.42%-31.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M37.70%-17.95M43.73%-18.77M50.69%-20.19M24.48%-88.39M136.54%14.71M9.78%-28.81M
Net income from continuing operations 14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M-341.39%-117.09M27.85%-24.6M64.98%-17.62M4.88%-166.01M-9.31%-55.08M48.18%-26.53M
Operating gains losses ---195K--337K--36.95M---63.51M------------------------
Depreciation and amortization -6.12%322K-1.81%325K16.98%1.37M1.10%366K19.49%331K25.64%343K27.31%331K138.21%1.17M73.21%362K66.87%277K
Other non cash items -93.92%247K-75.47%105K167.01%9.27M198.26%1.71M399.35%3.07M666.42%4.06M-75.58%428K-65.76%3.47M-80.46%574K-59.23%614K
Change In working capital -437.94%-4.28M105.96%298K-197.27%-18.01M-117.11%-4.85M3.57%-7.37M81.07%-796K-345.43%-5M-35.40%18.52M1,298.37%28.33M-161.17%-7.64M
-Change in prepaid assets -9.57%822K-73.25%-693K187.88%6.01M1,754.63%2M84.16%3.5M575.92%909K-247.60%-400K162.12%2.09M105.90%108K8.45%1.9M
-Change in payables and accrued expense -678.55%-3.99M3,938.53%4.4M49.95%-8.57M39.13%-3.25M35.83%-6.12M117.19%690K-93.82%109K-153.48%-17.13M-238.29%-5.33M-188.83%-9.54M
-Change in other working capital 53.57%-1.11M27.52%-3.41M-146.04%-15.45M---3.6M---4.75M---2.4M---4.71M--33.56M--------
Cash from discontinued investing activities
Operating cash flow -14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M37.70%-17.95M43.73%-18.77M50.69%-20.19M24.48%-88.39M136.54%14.71M9.78%-28.81M
Investing cash flow
Cash flow from continuing investing activities -518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K-15.56%-3.49M100.59%48K65.87%-3.9M-15.66%-24.93M72.18%-2.37M24.54%-3.02M
Net PPE purchase and sale -518.75%-201K96.41%-140K81.24%-3.87M99.26%-17K--0100.61%48K53.72%-3.9M-34.73%-20.62M72.08%-2.31M42.32%-2.02M
Net intangibles purchase and sale --------17.65%-3.5M--0------------32.00%-4.25M--0-100.00%-1M
Net other investing changes --------127.87%17K--7K---------------61K--------
Cash from discontinued investing activities
Investing cash flow -518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K-15.56%-3.49M100.59%48K65.87%-3.9M-15.66%-24.93M72.18%-2.37M24.54%-3.02M
Financing cash flow
Cash flow from continuing financing activities 18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M136,637.86%140.63M-96.60%377K-245.79%-370K33.30%52.1M352.85%41.23M-100.34%-103K
Net issuance payments of debt -----------3.45M------------------0--------
Net common stock issuance --------164.42%140.79M-101.02%-423K--140.71M----------53.24M--41.6M--0
Proceeds from stock option exercised by employees --0-48.00%26K-73.12%68K--0126.47%18K--0-81.95%50K--253K--0---68K
Net other financing activities 89.43%-13K88.57%-48K27.50%-1.02M-0.81%-375K-177.14%-97K79.80%-123K-9.38%-420K-60.18%-1.4M---372K---35K
Cash from discontinued financing activities
Financing cash flow 18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M136,637.86%140.63M-96.60%377K-245.79%-370K33.30%52.1M352.85%41.23M-100.34%-103K
Net cash flow
Beginning cash position 91.61%126.58M61.89%146.54M-40.35%90.52M351.82%166.92M-30.72%47.72M-33.45%66.06M-40.35%90.52M-39.61%151.74M-80.70%36.94M-65.10%68.88M
Current changes in cash 365.85%48.76M18.38%-19.96M191.51%56.02M-138.03%-20.38M473.27%119.2M39.65%-18.34M53.40%-24.46M38.48%-61.22M235.04%53.57M-436.06%-31.93M
End cash Position 267.44%175.34M91.61%126.58M61.89%146.54M61.89%146.54M351.82%166.92M-30.72%47.72M-33.45%66.06M-40.35%90.52M-40.35%90.52M-80.70%36.94M
Free cash flow -15.95%-21.71M17.22%-19.94M29.02%-80.39M-230.08%-16.13M32.61%-21.45M54.86%-18.72M54.01%-24.09M18.28%-113.26M125.43%12.4M11.42%-31.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data